Literature DB >> 34160127

RNA-binding protein RBM47 stabilizes IFNAR1 mRNA to potentiate host antiviral activity.

Kezhen Wang1, Chenxiao Huang1, Tao Jiang1, Zhiqiang Chen1, Minfei Xue1, Qi Zhang1, Jinyu Zhang1, Jianfeng Dai1.   

Abstract

The type I interferon (IFN-I, IFN-α/β)-mediated immune response is the first line of host defense against invading viruses. IFN-α/β binds to IFN-α/β receptors (IFNARs) and triggers the expression of IFN-stimulated genes (ISGs). Thus, stabilization of IFNARs is important for prolonging antiviral activity. Here, we report the induction of an RNA-binding motif-containing protein, RBM47, upon viral infection or interferon stimulation. Using multiple virus infection models, we demonstrate that RBM47 has broad-spectrum antiviral activity in vitro and in vivo. RBM47 has no noticeable impact on IFN production, but significantly activates the IFN-stimulated response element (ISRE) and enhances the expression of interferon-stimulated genes (ISGs). Mechanistically, RBM47 binds to the 3'UTR of IFNAR1 mRNA, increases mRNA stability, and retards the degradation of IFNAR1. In summary, this study suggests that RBM47 is an interferon-inducible RNA-binding protein that plays an essential role in enhancing host IFN downstream signaling.
© 2021 The Authors.

Entities:  

Keywords:  IFNAR1; RNA-binding protein 47; innate immunity; interferon-stimulated genes; virus infection

Mesh:

Substances:

Year:  2021        PMID: 34160127      PMCID: PMC8339671          DOI: 10.15252/embr.202052205

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   9.071


  48 in total

Review 1.  RNA-binding proteins: modular design for efficient function.

Authors:  Bradley M Lunde; Claire Moore; Gabriele Varani
Journal:  Nat Rev Mol Cell Biol       Date:  2007-06       Impact factor: 94.444

Review 2.  RNA-binding proteins control gene expression and cell fate in the immune system.

Authors:  Martin Turner; Manuel D Díaz-Muñoz
Journal:  Nat Immunol       Date:  2018-01-18       Impact factor: 25.606

3.  RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition.

Authors:  Yong-Eun Kim; Minho Won; Sung-Gwon Lee; Chungoo Park; Chang-Hwa Song; Kee K Kim
Journal:  Oncogene       Date:  2019-07-29       Impact factor: 9.867

4.  Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus.

Authors:  Samantha Blackham; Andrew Baillie; Fadel Al-Hababi; Katja Remlinger; Shihyun You; Robert Hamatake; Michael J McGarvey
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

5.  The RNA-binding protein RBM47 is a novel regulator of cell fate decisions by transcriptionally controlling the p53-p21-axis.

Authors:  Reiner U Jänicke; Dennis Sohn; Claudia Radine; Dominik Peters; Alina Reese; Judith Neuwahl; Wilfried Budach
Journal:  Cell Death Differ       Date:  2019-09-11       Impact factor: 15.828

6.  Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.

Authors:  Feng Ma; Bing Li; Yongxin Yu; Shankar S Iyer; Mingyu Sun; Genhong Cheng
Journal:  EMBO Rep       Date:  2015-01-08       Impact factor: 8.807

Review 7.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  T lymphocytes from chronic HCV-infected patients are primed for activation-induced apoptosis and express unique pro-apoptotic gene signature.

Authors:  Bin-Bin Zhao; Su-Jun Zheng; Lu-Lu Gong; Yu Wang; Cai-Feng Chen; Wen-Jing Jin; Ding Zhang; Xiao-Hui Yuan; Jian Guo; Zhong-Ping Duan; You-Wen He
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

9.  Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer.

Authors:  Sakari Vanharanta; Christina B Marney; Weiping Shu; Manuel Valiente; Yilong Zou; Aldo Mele; Robert B Darnell; Joan Massagué
Journal:  Elife       Date:  2014-06-04       Impact factor: 8.140

10.  RBM24 stabilizes hepatitis B virus pregenomic RNA but inhibits core protein translation by targeting the terminal redundancy sequence.

Authors:  Yongxuan Yao; Bo Yang; Huang Cao; Kaitao Zhao; Yifei Yuan; Yingshan Chen; Zhenhua Zhang; Yun Wang; Rongjuan Pei; Jizheng Chen; Xue Hu; Yuan Zhou; Mengji Lu; Chunchen Wu; Xinwen Chen
Journal:  Emerg Microbes Infect       Date:  2018-05-14       Impact factor: 7.163

View more
  6 in total

1.  Comprehensive characterization of posttranscriptional impairment-related 3'-UTR mutations in 2413 whole genomes of cancer patients.

Authors:  Wenqing Wei; Wenyan Gao; Qinglan Li; Yuhao Liu; Hongyan Chen; Yongping Cui; Zhongsheng Sun; Zhihua Liu
Journal:  NPJ Genom Med       Date:  2022-06-02       Impact factor: 6.083

Review 2.  RNA Binding Proteins as Pioneer Determinants of Infection: Protective, Proviral, or Both?

Authors:  Samantha Lisy; Katherine Rothamel; Manuel Ascano
Journal:  Viruses       Date:  2021-10-28       Impact factor: 5.048

Review 3.  RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer.

Authors:  Benoît Soubise; Yan Jiang; Nathalie Douet-Guilbert; Marie-Bérengère Troadec
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

Review 4.  Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses.

Authors:  Zhe Ge; Shuzhe Ding
Journal:  Front Cell Infect Microbiol       Date:  2022-09-14       Impact factor: 6.073

5.  RNA-binding protein RBM47 stabilizes IFNAR1 mRNA to potentiate host antiviral activity.

Authors:  Kezhen Wang; Chenxiao Huang; Tao Jiang; Zhiqiang Chen; Minfei Xue; Qi Zhang; Jinyu Zhang; Jianfeng Dai
Journal:  EMBO Rep       Date:  2021-06-23       Impact factor: 9.071

6.  Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.

Authors:  Mohammadarian Akbari; Mehdi Akhavan-Bahabadi; Navid Shafigh; Afshin Taheriazam; Bashdar Mahmud Hussen; Arezou Sayad; Mohadeseh Fathi; Mohammad Taheri; Soudeh Ghafouri-Fard; Mohammad Fathi
Journal:  Cytokine       Date:  2022-03-04       Impact factor: 3.861

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.